Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

22.12.24	Pfizer Just Reassured Investors, but Is the Stock a Buy? (MotleyFool)
20.12.24	U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer (Businesswire)
19.12.24	Pfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with Analysts (Businesswire)
19.12.24	Pfizer Could Soar to $36 Per Share, According to a Wall Street Analyst. Is It a Buy at Around $26? (MotleyFool)
17.12.24	Pfizer im Aufwind: Dow mit längster Minus-Serie seit 1978 (N-TV)
17.12.24	Stock Of The Day: Is Pfizer About To Break Out? Expect A New Uptrend If Resistance Breaks (Benzinga)
17.12.24	Pfizer Does Not Anticipate Material Changes To US Vaccine Policy From The Incoming Administration In 2025 (Benzinga)
17.12.24	Pfizer Provides Full-Year 2025 Guidance and Reaffirms Full-Year 2024 Guidance (Businesswire)
16.12.24	What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday? (Benzinga)
15.12.24	Is Pfizer a Millionaire Maker? (MotleyFool)
12.12.24	Pfizer Declares First-Quarter 2025 Dividend (Businesswire)
10.12.24	Arvinas-Pfizer Partner Cancer Drug Trial Shows 63% Clinical Benefit In Breast Cancer Patients (Benzinga)
10.12.24	Cracking The Code: Understanding Analyst Reviews For Pfizer (Benzinga)
10.12.24	Pfizer Invites Public to View and Listen to Webcast of December 17 Conference Call with Analysts to Provide Full-Year 2025 Financial Guidance (Businesswire)
08.12.24	November 2024: Experten empfehlen Pfizer-Aktie mehrheitlich zu halten (finanzen.net) Auch im November haben Experten die Pfizer-Aktie bewertet. Das sind die Ergebnisse.» mehr
05.12.24	Pfizer Showcases Scientific Leadership in Breast Cancer and Blood Disorders Across More than 100 Presentations at ASH and SABCS (Businesswire)
05.12.24	Should You Forget Pfizer and Buy These Unstoppable Stocks Instead? (MotleyFool)
29.11.24	Is This a New Reason to Buy Pfizer Stock Hand Over Fist? (MotleyFool)
28.11.24	Is Pfizer Stock in Trouble? (MotleyFool)
27.11.24	Billionaires Are Buying Up Beaten-Down Pfizer Stock. Should You Follow Their Lead? (MotleyFool)
25.11.24	FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge Pfizer In Lucrative Yet Competitive Market (Benzinga)
22.11.24	Pfizer Stock Drops 10% In November On News Of Kennedy's HHS Nomination (Benzinga)
20.11.24	Pfizer Unusual Options Activity For November 20 (Benzinga)
20.11.24	Pfizer promotes oncology chief to lead R&D as activist Starboard circles (Financial Times)
20.11.24	Pfizer names oncology chief and company veteran Boshoff as chief scientific officer (MarketWatch)
20.11.24	Pfizer Announces New Chief Scientific Officer and President, Research & Development (Businesswire)
20.11.24	Is It Time to Sell Eli Lilly and Pfizer Stocks? (MotleyFool)
20.11.24	European Commission Approves Pfizer’s HYMPAVZI™ (marstacimab) for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without Inhibitors (Businesswire)
15.11.24	Stock Of The Day: Is Pfizer Set Up To Rally? (Benzinga)
15.11.24	Unpacking the Latest Options Trading Trends in Pfizer (Benzinga)
15.11.24	Key Takeaways From Pfizer Analyst Ratings (Benzinga)
15.11.24	Palantir, Moderna, Pfizer, Alibaba, Tesla: Why These 5 Stocks Are On Investors' Radars Today (Benzinga)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	144.55	2.19 %	K V
Geberit	598.20	1.67 %	K V
Alcon	64.08	0.98 %	K V
Sonova Hldg	239.50	0.80 %	K V
Nestle	75.41	-0.63 %	K V
Zurich Insur Gr	575.40	-0.66 %	K V
UBS Group	32.10	-1.05 %	K V
Swiss Re	140.95	-1.19 %	K V
Swiss Life Hldg	834.00	-1.70 %	K V

Pfizer Aktie VALOR 1065272 / ISIN ARDEUT111424

Nachrichten zu Pfizer Inc Cert.Deposito Arg.Repr. 0.5 Shs

Aktien Top/Flop

Pfizer Peer Group Nachrichten

Meistgelesene Nachrichten